<DOC>
	<DOCNO>NCT01542502</DOCNO>
	<brief_summary>This randomize , double-blind , crossover pilot study measure safety feasibility Interleukin-1 ( IL-1 ) blockade Anakinra patient stable heart failure preserve ejection fraction .</brief_summary>
	<brief_title>Pilot Feasibility Study Safety Efficacy Anakinra Heart Failure With Preserved Ejection Fraction</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Interleukin 1 Receptor Antagonist Protein</mesh_term>
	<criteria>Symptoms sign congestive heart failure Recent Imaging Study ( &lt; 12 month ) show Left Ventricular Ejection Fraction ( LVEF ) &gt; 50 % Left Ventricular End Diastolic Volume Index ( LVEDVI ) &lt; 97ml/m2 Evidence abnormal Left Ventricular ( LV ) relaxation , filling , diastolic distensibility , diastolic stiffness show one following : 1 . Invasive Hemodynamic measurement mean Pulmonary Capillary Wedge pressure ( mPCW ) &gt; 12 Left Ventricular End Diastolic Pressure ( LVEDP ) &gt; 16 mmHg 2 . Tissue Doppler Echocardiogram E/E ' &gt; 15 E/E ' 815 one following Left Ventricular Hypertrophy ( LVH ) Atrial Fibrillation Left Atrial Enlargement E/A &lt; 0.5 + Deceleration Time ( DT ) &gt; 280 ( &gt; 50yrs age ) 3 . Biomarkers Brain Natriuretic Peptide ( BNP ) &gt; 200pg/mL Age &lt; 18 Recent change ( previous 3 month ) HF maintenance medication ( betablockers , angiotensin convert enzyme [ ACE ] inhibitor , aldosterone antagonist , vasodilator , cardiac glycoside , diuretic ) Hospitalization worsen Heart Failure ( HF ) acute decompensated HF within previous 12months Anticipated need cardiac resynchronization therapy ( CRT ) automatedimplantable cardioverter defibrillator ( AICD ) Angina electrocardiograph ( ECG ) change limit maximum exertion cardiopulmonary exercise test Active infection include chronic infection Active cancer Recent ( &lt; 14 day ) use antiinflammatory drug ( include NonSteroidal AntiInflammatory Drugs [ NSAIDs ] ) , Chronic inflammatory disorder ( include limit rheumatoid arthritis , systemic lupus erythematosus ) , malignancy , comorbidity limit survival ability complete study Pregnancy ( determine urine pregnancy test woman childbearing potential ) Inability give inform consent Other condition limit completion cardiopulmonary exercise test completion study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Heart failure preserve ejection fraction</keyword>
	<keyword>Diastolic heart failure</keyword>
	<keyword>Aerobic exercise performance</keyword>
</DOC>